JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$2.29B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.1B |
| 3 |
Vanguard Total International Bond ETF
BNDX
|
+$1.67B |
| 4 |
AbbVie
ABBV
|
+$1.6B |
| 5 |
ExxonMobil
XOM
|
+$1.5B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$3.99B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$1.15B |
| 4 |
Tesla
TSLA
|
+$1.05B |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.04% |
| 2 | Healthcare | 10.96% |
| 3 | Financials | 10.87% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VTLE
3376
DELISTED
Vital Energy
VTLE
| $2.65M | ﹤0.01% |
33,502
-79,031
| -70% | -$5.73M |
|
3377
Nordic American Tanker
NAT
$1.42B
| $2.65M | ﹤0.01% |
1,243,858
-310,717
| -20% | -$551K |
|
3378
PUT
Lemonade
LMND
$4.07B
| $2.64M | ﹤0.01% |
+100,000
| New | +$2.83M |
|
3379
PUT
Biogen
BIIB
$31B
| $2.63M | ﹤0.01% |
12,500
-50,500
| -80% | -$11M |
|
|
TECX
3380
Tectonic Therapeutic
TECX
$682M
| $2.63M | ﹤0.01% |
166,199
-211,837
| -56% | -$4.38M |
|
3381
CALL
Accenture
ACN
$108B
| $2.63M | ﹤0.01% |
7,800
| – | – |
|
3382
Insmed
INSM
$27B
| $2.63M | ﹤0.01% |
111,702
+15,774
| +16% | +$367K |
|
|
CPAR
3383
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
| $2.63M | ﹤0.01% |
+269,885
| New | +$2.62M |
|
|
MNM
3384
DELISTED
Direxion Daily Metal Miners Bull 2X Shares
MNM
| $2.63M | ﹤0.01% |
50,000
| – | – |
|
3385
Simulations Plus
SLP
$371M
| $2.62M | ﹤0.01% |
51,431
+41,286
| +407% | +$1.77M |
|
3386
State Street SPDR S&P Transportation ETF
XTN
$395M
| $2.62M | ﹤0.01% |
29,425
-9,587
| -25% | -$838K |
|
|
FSR
3387
DELISTED
Fisker Inc.
FSR
| $2.62M | ﹤0.01% |
202,946
-204,094
| -50% | -$2.56M |
|
3388
Lyell Immunopharma
LYEL
$342M
| $2.62M | ﹤0.01% |
25,920
+2,702
| +12% | +$327K |
|
3389
ESCO Technologies
ESE
$7.92B
| $2.61M | ﹤0.01% |
37,374
-4,961
| -12% | -$378K |
|
3390
Eos Energy Enterprises
EOSE
$1.46B
| $2.61M | ﹤0.01% |
624,856
+608,260
| +3,665% | +$2.51M |
|
3391
CALL
Kimberly-Clark
KMB
$36.7B
| $2.61M | ﹤0.01% |
+21,200
| New | +$2.8M |
|
|
3392
PUT
Kimberly-Clark
KMB
$36.7B
| $2.61M | ﹤0.01% |
+21,200
| New | +$2.8M |
|
3393
SPDR Gold MiniShares Trust
GLDM
$30B
| $2.6M | ﹤0.01% |
67,709
+67,230
| +14,035% | +$2.51M |
|
3394
Metallus
MTUS
$904M
| $2.6M | ﹤0.01% |
118,961
-111,712
| -48% | -$1.96M |
|
3395
Astrana Health
ASTH
$2.02B
| $2.6M | ﹤0.01% |
53,559
+9,293
| +21% | +$479K |
|
3396
CALL
Nutrien
NTR
$32.6B
| $2.59M | ﹤0.01% |
+24,900
| New | +$2.06M |
|
|
MTVC.U
3397
DELISTED
Motive Capital Corp II Units, each consisting of one Class A ordinary share, and one-third of one redeemable warrant
MTVC.U
| $2.58M | ﹤0.01% |
252,872
-21,472
| -8% | -$214K |
|
3398
CALL
Yum China
YUMC
$16.3B
| $2.57M | ﹤0.01% |
61,800
+19,400
| +46% | +$914K |
|
3399
Riot Platforms
RIOT
$7.14B
| $2.57M | ﹤0.01% |
121,187
+17,600
| +17% | +$318K |
|
|
BIG
3400
DELISTED
Big Lots, Inc.
BIG
| $2.57M | ﹤0.01% |
74,176
-151,426
| -67% | -$5.95M |
|
Similar funds
JP Morgan Chase's Q1 2022 Portfolio in Review
As of Q1 2022, JP Morgan Chase held 7,378 positions worth $830B, down 4.1% from $866B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2022 filing shows 607 new, 2,657 increased, 2,665 reduced and 679 closed positions. Its largest new stake was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M. The largest sale was Vanguard Short-Term Bond ETF, an estimated $3.99B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2022 buy was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M.
- JP Morgan Chase added most to Vanguard Total Bond Market in Q1 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q1 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $3.99B.
- JP Morgan Chase fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $442M.
- JP Morgan Chase's ten largest holdings make up 18% of its $830B portfolio in Q1 2022.
- JP Morgan Chase opened 607 new positions and closed 679 in Q1 2022.
- JP Morgan Chase's portfolio value fell 4.1% quarter-over-quarter to $830B.
Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.